Xanthine derivatives as adenosine receptor antagonists

Area of Science:

• Pharmacology
• Neuroscience
• Biochemistry

Background:

• Adenosine receptors (A1 and A2) play crucial roles in cellular function and neurotransmission.
• Xanthine derivatives are known modulators of adenosine receptor activity.
• Understanding structure-activity relationships is key for developing selective receptor antagonists.

Purpose of the Study:

• To evaluate the potency of various xanthine derivatives as adenosine antagonists.
• To compare antagonist activity across different adenosine receptor subtypes (A1 and A2) and brain regions.
• To establish the relative order of potency for a series of substituted xanthines.

Main Methods:

• Assessed antagonist potency using fat cells (A1-receptors) and hippocampal slices (A2-receptors).
• Measured L-[3H]phenylisopropyladenosine (PIA) binding in rat cortical membranes.
• Quantified the binding affinities and functional effects of different xanthine derivatives.

Main Results:

• A clear order of potency was established across all tested systems: diethyl-8-phenyl-theophylline > 8-phenyltheophylline > 8-p-sulfophenyltheophylline > verrophylline > isobutylmethylxanthine > theophylline/caffeine > theobromine.
• Enprofylline demonstrated significantly higher potency (approximately 20-fold) in the hippocampal (A2-receptor) system compared to fat cells (A1-receptor) and cortical membranes.
• Diethyl-8-phenyl-theophylline emerged as the most potent antagonist in the tested series.

Conclusions:

• Structural modifications of the xanthine core significantly influence adenosine receptor antagonist potency.
• Diethyl-8-phenyl-theophylline is a highly potent adenosine receptor antagonist.
• Enprofylline exhibits a distinct pharmacological profile, with enhanced potency at A2 receptors in the hippocampus, suggesting potential for region-specific applications.